C
RGNX icon

Covestor’s Regenxbio RGNX Stock Holding History

Covestor’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
23
+16
+229% +$133 ﹤0.01% 2783
2026
Q1 		$0 Sell
7
-1,523
-100% -$16K ﹤0.01% 2692
2025
Q4 		$22K Sell
1,530
-199
-12% -$2.48K 0.01% 1254
2025
Q3 		$17K Sell
1,729
-8
-0.5% -$71 0.01% 1342
2025
Q2 		$14K Buy
1,737
+1,730
+24,714% +$14.5K 0.01% 1384
2025
Q1 		$0 Hold
7
– – ﹤0.01% 2644
2024
Q4 		$0 Hold
7
– – ﹤0.01% 2648
2024
Q3 		$0 Buy
7
+3
+75% +$37 ﹤0.01% 2663
2024
Q2 		$0 Sell
4
-18
-82% -$280 ﹤0.01% 2661
2024
Q1 		$0 Buy
22
+12
+120% +$214 ﹤0.01% 2645
2023
Q4 		$0 Sell
10
-1
-9% -$18 ﹤0.01% 2615
2023
Q3 		$0 Sell
11
-3
-21% -$54 ﹤0.01% 2607
2023
Q2 		$0 Buy
14
+9
+180% +$173 ﹤0.01% 2555
2023
Q1 		$0 Hold
5
– – ﹤0.01% 2478
2022
Q4 		$0 Sell
5
-1
-17% -$23 ﹤0.01% 2504
2022
Q3 		$0 Sell
6
-6
-50% -$178 ﹤0.01% 2481
2022
Q2 		$0 Buy
12
+3
+33% +$75 ﹤0.01% 2285
2022
Q1 		$0 Sell
9
-2
-18% -$56 ﹤0.01% 2386
2021
Q4 		$0 Buy
+11
New +$375 ﹤0.01% 2274

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Covestor's RGNX Position: Q2 2026 in Review

Covestor increased its Regenxbio (RGNX) stake by 229% in Q2 2026, buying an estimated $133 and bringing the position to 23 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2783.

Covestor first reported a position in RGNX in Q4 2021 and has held it in 19 quarters since. The position peaked at $22K in Q4 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Covestor held 23 shares of Regenxbio worth $0 as of Q2 2026.
  • Covestor bought 16 Regenxbio shares in Q2 2026, an estimated $133.
  • Regenxbio made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2783 holding.
  • Covestor first reported a position in Regenxbio in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Regenxbio position peaked at $22K in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.